A Prospective Study to Evaluate the Impact of Golimumab Therapy on Work Productivity and Activity, and Quality of Life in Patients With Rheumatoid Arthritis, Psoriasis Arthritis and Axial Spondyloarthritis in a Real Life Setting in AUSTRIA. The GO-ACTIVE Study.

Christian Dejaco, Thomas Mueller, Omid Zamani, Ulrike Kurtz, Stefan Egger, Johannes Resch-Passini, Anna Totzauer, Babak Yazdani-Biuki, Thomas Schwingenschloegl, Peter Peichl, Angelika Kraus, Gerhard W Naerr

Research output: Contribution to journalOriginal Articlepeer-review

2 Citations (Web of Science)
Original languageEnglish
Pages (from-to)881943
JournalFRONTIERS IN MEDICINE
Volume9
DOIs
Publication statusPublished - 2022

Keywords

  • NECROSIS-FACTOR-ALPHA
  • ACTIVITY IMPAIRMENT
  • RELIABILITY
  • DISABILITY
  • EFFICACY
  • VALIDITY
  • ANTIBODY
  • SAFETY

Cite this